查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1413854

再生醫學中的人工智慧市場：按技術、產品、應用和最終用戶分類 - 2024-2030 年全球預測

Artificial Intelligence in Regenerative Medicine Market by Technology (Computer Vision, Context-Aware Computing, Machine Learning), Offering (Hardware, Services, Software), Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年人工智慧再生醫學市場規模為5,963萬美元，2024年將達7,238萬美元，2030年將達2,4063萬美元，複合年成長率為22.05%。

再生醫學人工智慧的全球市場

主要市場統計
基準年[2023] 5963萬美元
預測年份 [2024] 7238萬美元
預測年份 [2030] 2.4063億美元
複合年成長率（%） 22.05%
人工智慧在再生醫學市場-IMG1

人工智慧（AI）在再生醫學中越來越重要，因為它是一種修復、替換和再生人體內受損或失去的組織和器官的多學科方法。人工智慧技術正在應用於再生醫學的各個方面，以加速研究、加強患者照護並改善治療結果。再生醫學市場中的人工智慧包括將機器學習演算法、深度學習系統、自然語言處理工具和機器人等人工智慧技術整合到幹細胞療法、組織工程、免疫療法和基因編輯技術中。公共和私營部門對研發活動的資金增加正在加速人工智慧等先進技術的採用。此外，癌症和心血管疾病等慢性疾病的盛行率不斷上升，需要創新的治療方法，而這些方法只能透過人工智慧驅動的再生醫學提供的突破性解決方案來解決，需求不斷增加，市場成長進一步加快。然而，用於訓練人工智慧演算法的患者資訊的敏感性引發了資料隱私問題，而人工智慧系統使用的複雜演算法阻礙了市場的採用。個體化治療的出現和次世代定序(NGS) 技術的進步正在產生大量需要先進分析技術的資料，為人工智慧在再生醫學中的應用創造了新的機會。

區域洞察

由於擁有大量投資、合作夥伴關係以及持續關注市場創新的主要市場參與者，美洲在再生醫學人工智慧市場中佔據關鍵地位。此外，政府的主導正在匯集各領域的研究人員，專注於整合人工智慧技術，開發器官再生和修復的新治療方法。在歐盟 (EU)，地平線 2020 等資助計畫正在分配大量資源來推進以人工智慧為基礎的再生醫學計劃。政府推出了幾個計劃，使用機器學習演算法來繪製人類的每種細胞類型，進一步刺激了該地區的市場採用。在政府大量投資的支持下，亞太地區正在快速推動以人工智慧為基礎的再生醫學。主要公司正在建立專門的醫療保健部門，將人工智慧技術應用於醫療問題，包括再生療法。政府也啟動了戰略舉措，開發再生醫學人工智慧技術，以支持醫療保健和生物技術等產業，進一步加速該地區的市場採用。

FPNV定位矩陣

FPNV定位矩陣對於評估再生醫學市場的人工智慧至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對再生醫學市場人工智慧供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-再生醫學人工智慧市場的市場規模和預測是多少？

2-在再生醫學市場的人工智慧預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3-再生醫學人工智慧市場的技術趨勢和法律規範是什麼？

4-再生醫學人工智慧市場主要廠商的市場佔有率是多少？

5-進入再生醫學人工智慧市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病和罕見病患疾病率增加
      • 消費者對精準醫療和幹細胞治療的偏好日益成長
      • 政府支持將人工智慧引入醫療保健領域
    • 抑制因素
      • 基於人工智慧的再生醫學解決方案相關的高成本
    • 機會
      • 改善藥物研發與開發的技術進步
      • 增加人工智慧實施的資金和投資
    • 任務
      • 資料隱私問題和熟練專業人員的可用性有限
  • 市場區隔分析
    • 技術：大量採用電腦視覺技術，準確且有效率地偵測重要生物結構
    • 產品：硬體提供再生醫學中人工智慧應用所需的運算能力。
    • 應用範例：在藥物研發發現應用中利用 AL 技術的可能性
    • 最終用戶：製藥和生物技術公司專注於利用人工智慧加速藥物研發
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章再生醫學中的人工智慧市場：按技術分類

  • 電腦視覺
  • 情境感知計算
  • 機器學習
  • 自然語言處理

第7章再生醫學中的人工智慧市場：透過提供

  • 硬體
    • 記憶
    • 通訊網路
    • 處理器
  • 服務
  • 軟體

第8章再生醫學中的人工智慧市場：按應用分類

  • 網路安全
  • 藥物研發
  • 詐欺識別
  • 醫療保健支援機器人
  • 醫療圖像與診斷
  • 患者資料和風險分析
  • 精準醫療

第9章再生醫學中的人工智慧市場：按最終用戶分類

  • 醫療保健付款人
  • 醫院和醫療保健提供者
  • 製藥和生物技術公司

第10章美洲再生醫學人工智慧市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區再生醫學人工智慧市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章：歐洲、中東和非洲再生醫學領域的人工智慧市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析
    • 併購
    • 合約、合作和夥伴關係

第14章競爭產品組合

  • 主要公司簡介
    • Cognetivity Ltd.
    • F. Hoffmann-La Roche Ltd.
    • Intel Corporation
    • Medtronic PLC
    • Merck KGaA
    • Microsoft Corporation
    • NANO-X IMAGING LTD.
    • Novo Nordisk A/S
    • NVIDIA Corporation
    • Sanofi SA
    • Tempus Labs, Inc.
    • Wipro Limited
  • 主要產品系列

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-A6768A62EE04

[196 Pages Report] The Artificial Intelligence in Regenerative Medicine Market size was estimated at USD 59.63 million in 2023 and expected to reach USD 72.38 million in 2024, at a CAGR 22.05% to reach USD 240.63 million by 2030.

Global Artificial Intelligence in Regenerative Medicine Market

KEY MARKET STATISTICS
Base Year [2023] USD 59.63 million
Estimated Year [2024] USD 72.38 million
Forecast Year [2030] USD 240.63 million
CAGR (%) 22.05%
Artificial Intelligence in Regenerative Medicine Market - IMG1

Artificial intelligence (AI) is increasingly important in regenerative medicine as it is a multidisciplinary approach to repairing, replacing, or regenerating damaged or lost tissues and organs within the human body. AI technologies are applied to various aspects of regenerative medicine to accelerate research, enhance patient care, and improve treatment outcomes. The AI in the regenerative medicine market encompasses integrating AI technologies such as machine learning algorithms, deep learning systems, natural language processing tools, and robotics with stem cell therapy, tissue engineering, immunotherapies, and gene editing techniques. Increased funding for research & development activities in both public and private sectors has accelerated the adoption of advanced technologies such as AI. Additionally, the rising prevalence of chronic conditions such as cancer and cardiovascular diseases has increased demand for innovative treatment approaches that can only be met through groundbreaking solutions provided by AI-enabled regenerative medicine, further increasing market growth. However, data privacy concerns arise due to the sensitive nature of patient information used for training AI algorithms, and the complex algorithms used by AI systems hamper market adoption. The advent of personalized therapy and advances in next-generation sequencing (NGS) technologies have generated vast amounts of data requiring sophisticated analysis methods; this poses yet another opportunity for AI's application within the regenerative medicine landscape.

Regional Insights

The Americas hold a significant landscape in the artificial intelligence in regenerative medicine market owing to significant investments and partnerships and the presence of key market players continuously focusing on innovations in the market. Additionally, the government initiative brings together researchers from various fields who focus on integrating AI technologies to develop novel therapeutic approaches for organ regeneration and repair. In the European Union, funding programs such as Horizon 2020 have allocated substantial resources to advance AI-based regenerative medicine projects. The government has launched several projects to map every human cell type using machine learning algorithms, further fueling the region's market adoption. APAC region is rapidly advancing in AI-based regenerative medicine, backed by significant government investments. Leading companies have established dedicated healthcare units that apply AI technologies to medical issues, including regenerative therapies. The government has also launched strategic initiatives to develop AI technologies for regenerative medicine to support industries such as healthcare and biotechnology, further fueling market adoption in the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Artificial Intelligence in Regenerative Medicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Artificial Intelligence in Regenerative Medicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Artificial Intelligence in Regenerative Medicine Market, highlighting leading vendors and their innovative profiles. These include Cognetivity Ltd., F. Hoffmann-La Roche Ltd., Intel Corporation, Medtronic PLC, Merck KGaA, Microsoft Corporation, NANO-X IMAGING LTD., Novo Nordisk A/S, NVIDIA Corporation, Sanofi SA, Tempus Labs, Inc., and Wipro Limited.

Market Segmentation & Coverage

This research report categorizes the Artificial Intelligence in Regenerative Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technology
    • Computer Vision
    • Context-Aware Computing
    • Machine Learning
    • Natural Language Processing
  • Offering
    • Hardware
      • Memory
      • Network
      • Processor
    • Services
    • Software
  • Application
    • Cybersecurity
    • Drug Discovery
    • Fraud Detection
    • Healthcare Assistance Robots
    • Medical Imaging & Diagnostics
    • Patient Data & Risk Analysis
    • Precision Medicine
  • End-User
    • Healthcare Payers
    • Hospitals & Providers
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Artificial Intelligence in Regenerative Medicine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Artificial Intelligence in Regenerative Medicine Market?

3. What are the technology trends and regulatory frameworks in the Artificial Intelligence in Regenerative Medicine Market?

4. What is the market share of the leading vendors in the Artificial Intelligence in Regenerative Medicine Market?

5. Which modes and strategic moves are suitable for entering the Artificial Intelligence in Regenerative Medicine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Artificial Intelligence in Regenerative Medicine Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic and rare diseases
      • 5.1.1.2. Growing consumer preference for precision medicines and stem cell therapies
      • 5.1.1.3. Supportive government initiatives for deployment of AI in healthcare sector
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with AI-based solutions for regenerative medicine
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in technologies for improved drug discovery and development
      • 5.1.3.2. Rising funding and investments for deployment of AI
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding data privacy coupled with limited availability of skilled professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Significant adoption of computer vision technology for accurate and efficient detection of key biological structures
    • 5.2.2. Offering: Hardware provides the necessary computational power in AI applications in regenerative medicine
    • 5.2.3. Application: Potential utilization of AL technology in drug discovery applications
    • 5.2.4. End-User: Pharmaceutical and biotechnology companies focus on leveraging AI to accelerate drug discovery
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Artificial Intelligence in Regenerative Medicine Market, by Technology

  • 6.1. Introduction
  • 6.2. Computer Vision
  • 6.3. Context-Aware Computing
  • 6.4. Machine Learning
  • 6.5. Natural Language Processing

7. Artificial Intelligence in Regenerative Medicine Market, by Offering

  • 7.1. Introduction
  • 7.2. Hardware
    • 7.3.1. Memory
    • 7.3.2. Network
    • 7.3.3. Processor
  • 7.3. Services
  • 7.4. Software

8. Artificial Intelligence in Regenerative Medicine Market, by Application

  • 8.1. Introduction
  • 8.2. Cybersecurity
  • 8.3. Drug Discovery
  • 8.4. Fraud Detection
  • 8.5. Healthcare Assistance Robots
  • 8.6. Medical Imaging & Diagnostics
  • 8.7. Patient Data & Risk Analysis
  • 8.8. Precision Medicine

9. Artificial Intelligence in Regenerative Medicine Market, by End-User

  • 9.1. Introduction
  • 9.2. Healthcare Payers
  • 9.3. Hospitals & Providers
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Artificial Intelligence in Regenerative Medicine Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Artificial Intelligence in Regenerative Medicine Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Artificial Intelligence in Regenerative Medicine Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Merger & Acquisition
      • 13.3.1.1. Axolotl Biologix and Carmell Therapeutics Enter Merger Deal
    • 13.3.2. Agreement, Collaboration, & Partnership
      • 13.3.2.1. Epredia and Aiforia Join RegenMed Hub Innovation Accelerator, Expanding PHC Group Presence in Regenerative Medicine Partnership Will Pave the Way for New RegenMed Clinical Trials Catalyst Program
      • 13.3.2.2. Wipro and Pandorum Partner to Accelerate Regenerative Medicine with Artificial Intelligence

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Cognetivity Ltd.
    • 14.1.2. F. Hoffmann-La Roche Ltd.
    • 14.1.3. Intel Corporation
    • 14.1.4. Medtronic PLC
    • 14.1.5. Merck KGaA
    • 14.1.6. Microsoft Corporation
    • 14.1.7. NANO-X IMAGING LTD.
    • 14.1.8. Novo Nordisk A/S
    • 14.1.9. NVIDIA Corporation
    • 14.1.10. Sanofi SA
    • 14.1.11. Tempus Labs, Inc.
    • 14.1.12. Wipro Limited
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET DYNAMICS
  • FIGURE 7. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 8. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 10. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CONTEXT-AWARE COMPUTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 11. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 13. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MEMORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NETWORK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PROCESSOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CYBERSECURITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FRAUD DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HEALTHCARE ASSISTANCE ROBOTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MEDICAL IMAGING & DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PATIENT DATA & RISK ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PRECISION MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HEALTHCARE PAYERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HOSPITALS & PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 240. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 241. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET LICENSE & PRICING